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Relationship Between Increased Serum Resistin Levels and Coronary Artery
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Introductıon: Resistin which is derived by the gene of RSTN, belongs to a family
cysteine-rich secretory proteins called resistin-like molecules (RELM). It was ﬁrst
characterized in murine models as a hormone associated with obesity and insulin
resistance. The increased serum resistin levels are associated with coronary artery
disease (CAD) and the risk of cardiovascular (CV) death.
Materıal-Method: The study group consisted of 214 patients who underwent coro-
nary angiogram due to stable angina pectoris (SAP) or unstable angina pectoris
(USAP) and acute coronary syndrome without ST segment elevation myocardial
infarction (NSTEMI) in Istanbul University Institute of Cardiology between
December 2011 and December 2012. Blood samples were collected from each patient
before coronary angiography; 5 ml of blood were drawn in tubes without anticoag-
ulant. Serum resistin concentrations were measured by using a Human Resistin ELISA
assay (Biovendor Company, German). Coronary angiography was performed in all
patients. CAD was deﬁned by a plaque in at least 1 major coronary artery. The Gensini
score was used to determine the severity and extension of CAD.
Results: The serum resistin level in the CAD group (25.5015.44 pg/ml) was
signiﬁcantly higher than the control group (17.128.26 pg/ml) (p:0.003). The serum
resistin level was 25.3913.36 pg/ml in the SAP (p<0.05), 24.9518.01 pg/ml in the
USAP (p<0.05), 28.1616.48 pg/ml in the NSTEMI (p<0.05) groups (Table 1).
Whereas there was no signiﬁcant difference in the serum resistin levels between
NSTEMI, USAP and SAP groups (Table 2). There was a positive correlation between
Gensini score and serum resistin levels (r¼0.360, p¼0.010) according to Spearman's
correlation analysis (Table 3 and Figure 1).C186 JACC VoDıscussıon: In our study we found that serum resistin levels were signiﬁcantly
increased in NSTEMI, USAP and SAP when compared with the controls (p:0.003).
Reilly et al. reported that serum resistin level was independently associated with
coronary artery calciﬁcation (CAC). In contrast to our study, Qiao et al. reported
serum resistin levels increased with the progress of CAD. In their study serum resistin
levels were elevated in the USAP group compared with the SAP group, while the level
was highest in AMI (acute myocardial infarction) patients (p<0.05). In our study there
was a positive correlation between the Gensini score and serum resistin level. This
makes our study different from others because we did not ﬁnd any study examining
the correlation between serum resistin level and Gensini score. In conclusion, we
found that there was a relationship between increased serum resistin level and CAD.
Also, the serum resistin level was positively correlated with the Gensini score. These
observations suggest that resistin may participate in the process of atherosclerosis as
an effector molecule of inﬂammatory reaction. Further investigation is needed to
deﬁne the role of resistin in patients with CAD.l 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
